Focus
- Volume 5
- Number 2
- April 2007
FROM THE GUEST EDITOR
CLINICAL SYNTHESIS
Publication date: 01 April 2007
Pages141–150In this review, we highlight recent developments in the pharmacological treatment of alcohol and other substance use disorders and in programs designed for those with dual diagnosis disorders. The depot formulation of naltrexone, which recently received ...
https://doi.org/10.1176/foc.5.2.foc141Publication date: 01 April 2007
Pages151–162Substance abuse continues to be a major source of morbidity and mortality around the world. Preclinical research on substance abuse continues to focus on determining the neurobiological substrates underlying this disorder and using this information to ...
https://doi.org/10.1176/foc.5.2.foc151Publication date: 01 April 2007
Pages163–166Since the publication in May 2006 of APA's Practice Guideline for the Treatment of Patients With Substance Use Disorders, 2nd Edition (), results have been reported for a multisite randomized, controlled trial evaluating the efficacy of medication, ...
https://doi.org/10.1176/foc.5.2.foc163Publication date: 01 April 2007
Pages172–183This exercise is designed to test your comprehension of material presented in this issue of FOCUS as well as your ability to evaluate, diagnose, and manage clinical problems. Answer the questions below, to the best of your ability, on the basis of the ...
https://doi.org/10.1176/foc.5.2.foc172INFLUENTIAL PUBLICATIONS
Publication date: 01 April 2007
Pages184–186This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and ...
https://doi.org/10.1176/foc.5.2.foc184ERRATUM
INFLUENTIAL PUBLICATIONS
Publication date: 01 April 2007
Pages193–198Background: Accumulating evidence indicates that addiction and psychiatric treatment programs that actively promote self-help group involvement can reduce their patients' health care costs in the first year after treatment, but such initially impressive ...
https://doi.org/10.1176/foc.5.2.foc193Publication date: 01 April 2007
Pages199–207Aims: This article reviews the problems of cross-cultural applicability, which have been identified at the level of instrument items, at the level of criteria, and at the level of concepts and diagnoses. One near-universal appears to be that the diagnoses ...
https://doi.org/10.1176/foc.5.2.foc199Publication date: 01 April 2007
Pages208–219Objective: A primary behavioral pathology in drug addiction is the overpowering motivational strength and decreased ability to control the desire to obtain drugs. In this review the authors explore how ...
https://doi.org/10.1176/foc.5.2.foc208Publication date: 01 April 2007
Pages220–228If neurobiology is ultimately to contribute to the development of successful treatments for drug addiction, researchers must discover the molecular mechanisms by which drug-seeking behaviors are consolidated into compulsive use, the mechanisms that ...
https://doi.org/10.1176/foc.5.2.foc220Publication date: 01 April 2007
Pages229–239The high rate of co-occurrence of substance use disorders and other psychiatric disorders is well established. The population of people with co-occurring disorders is heterogeneous, and the prevalence of comorbidity differs by diagnostic group. One of the ...
https://doi.org/10.1176/foc.5.2.foc229Publication date: 01 April 2007
Pages240–248The past three decades have been marked by tremendous progress in behavioral therapies for drug abuse and dependence, as well as advances in the conceptualization of approaches to development of behavioral therapies. Cognitive behavior therapy, ...
https://doi.org/10.1176/foc.5.2.foc240Publication date: 01 April 2007
Pages249–261This practice parameter describes the assessment and treatment of children and adolescents with substance use disorders and is based on scientific evidence and clinical consensus regarding diagnosis and effective treatment as well as on the current state ...
https://doi.org/10.1176/foc.5.2.foc249Publication date: 01 April 2007
Pages262–269Comorbidity of substance abuse disorders (SUD) with bipolar disorders (BPD) is a serious treatment problem. Childhood BPD can be further complicated by comorbidity with attention-deficit/hyperactivity disorder (ADHD) and later SUD during adolescence. The ...
https://doi.org/10.1176/foc.5.2.foc262Publication date: 01 April 2007
Pages270–278Background: Controversy remains as to whether cannabis acts as a causal risk factor for schizophrenia or other functional psychotic illnesses. Aims: To examine critically the evidence that cannabis causes psychosis using established criteria of causality. ...
https://doi.org/10.1176/foc.5.2.foc270Past Issues
View Issues Archive
Vol. 22 | No. 4
Vol. 22 | No. 3
Vol. 22 | No. 2
